Old Web
English
Sign In
Acemap
>
authorDetail
>
Alison Greene
Alison Greene
Johnson & Johnson Pharmaceutical Research and Development
Physical therapy
Tapentadol
Medicine
Osteoarthritis
Controlled release
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
333 SHORT FORM-36 (SF-36) AND EUROQOL-5 DIMENSION (EQ-5D) RESULTS FROM RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDIES OF TAPENTADOL PROLONGED RELEASE (PR) IN PATIENTS WITH MODERATE TO SEVERE CHRONIC NOCICEPTIVE AND NEUROPATHIC PAIN
2010
Osteoarthritis and Cartilage
R. Lange
B. Lange
Alison Greene
Akiko Okamoto
M. Etropolski
Judy Ashworth
Show All
Source
Cite
Save
Citations (1)
Poster 50: Health-related Functional Status Evaluations in Patients with Osteoarthritis Pain Treated With Tapentadol Extended Release
2009
Pm&r
Brigitte Kuperwasser
Marc Afilalo
Mila Etropolski
Alison Greene
J. Haeussler
Kathleen Kelly
Bernd Lange
Show All
Source
Cite
Save
Citations (0)
337 EVALUATION OF LONG-TERM TREATMENT WITH TAPENTADOL EXTENDED RELEASE AND OXYCODONE CONTROLLED RELEASE IN PATIENTS WITH CHRONIC LOW BACK OR OSTEOARTHRITIS PAIN: RESULTS FROM PATIENT AND PHYSICIAN GLOBAL ASSESSMENTS AND THE EUROQOL 5 DIMENSION QUESTIONNAIRE
2009
Osteoarthritis and Cartilage
Brigitte Kuperwasser
R. Lange
Bettyanne McCann
Alison Greene
M. Etropolski
B. Lange
Jane S. Gilbert
Akiko Okamoto
A. Steup
Christine Rauschkolb
Show All
Source
Cite
Save
Citations (0)
1